Public Company News

Yum China Commits to the Science Based Targets Initiative to Reinforce its Climate Action Efforts

SHANGHAI, June 8, 2021 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) today announced that it has signed the Business Ambition for 1.5⁰C Commitment Letter, as part of the global Science Based Targets initiative (SBTi), that helps companies estab...

2021-06-08 16:30 7230

GWM's Globalization Strategy is accelerated on 2nd Anniversary of Tula Factory in Russia

BAODING, China, June 8, 2021 /PRNewswire/ -- June 5 witnessed the second anniversary of the operation of GWM's Tula factory inRussia. Since the first batch of HAVAL F7, HAVAL F7x, HAVAL H9 and other models got mass-produced, HAVAL-branded automobiles have ranked high in sales volume for many year...

2021-06-08 16:23 21002

Zhangmen Education Inc. Announces Pricing of Initial Public Offering

SHANGHAI, June 8, 2021 /PRNewswire/ -- Zhangmen Education Inc. ("Zhangmen" or the "Company") (NYSE: ZME), a leading online education company inChina focused on providing personalized online courses to K-12 students, today announced the pricing of its initial public offering (the "IPO") of 3,623,0...

2021-06-08 16:20 16800

AVerMedia launches Live Streamer NEXUS and MIC 330, a content creator control center/6-track audio mixer and a dynamic XLR microphone

TAIPEI, June 8, 2021 /PRNewswire/ -- AVerMedia Technologies, Inc., a leader in digital audio and video, today announced it has launched the Live StreamerNEXUS and Live Streamer MIC 330 , the lat...

2021-06-08 16:00 3337

Momo Announces Unaudited Financial Results for the First Quarter of 2021

BEIJING, June 8, 2021 /PRNewswire/ -- Momo Inc. (NASDAQ: MOMO) ("Momo" or the "Company"), a leading mobile social and entertainment platform inChina, today announced its unaudited financial results for the first quarter of 2021. First Quarter of 2021 Highlights * Net revenues decreased by 3.4%...

2021-06-08 15:45 16751

Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

SHENZHEN, China, June 8, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced theNuewa I9 , its l...

2021-06-08 15:37 10165

iHuman Inc. Announces First Quarter 2021 Unaudited Financial Results

BEIJING, June 8, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("Human" or the "Company"), a leading childhood edutainment company inChina, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights * Total revenues were RMB226.7...

2021-06-08 13:47 16985

Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company

HONG KONG, June 8, 2021 /PRNewswire/ -- Ying Hai Group Holdings Company Limited ("the Company" or "Ying Hai Group", together with its subsidiaries, the "Group", HKSE stock code: 8668) is pleased to announce that, the Group will acquire Zhuhai Huanya International Tourism Co., Ltd. ("Target Comp...

2021-06-08 11:35 15829

A Snapshot of SID Display Week 2021: BOE leads the way in display industry, bringing momentum to "China's moment"

BEIJING, June 7, 2021 /PRNewswire/ -- The below news release is from DINGKEJI.COM about BOE Technology Group: In order to move forward, you have to leave where you are now -- this is an inspirational quote from bestsellerUnder the Tuscan Sun. With the rapid advancement of display technology, t...

2021-06-08 11:17 7019

Pearl Abyss Releases BUGATTI Collaboration for Black Desert

SEOUL, South Korea, June 8, 2021 /PRNewswire/ -- Pearl Abyss today announced a collaboration with BUGATTI. The prestigious French brand will appear across the world ofBlack Desert across all platforms. Adventurers can now enjoy this collaboration through special quests and branded items.   

2021-06-08 10:47 3139

Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress

SAN FRANCISCO and SUZHOU, China, June 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-08 08:00 5491

Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL

SUZHOU, China, and ROCKVILLE, MD, June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released updated results from the first...

2021-06-08 07:30 5475

Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs

SUZHOU, China, and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented in an oral presentation at t...

2021-06-08 07:21 12835

TIAN RUIXIANG Holdings Ltd Announces Initial Closing of Follow-on Public Offering

BEIJING, June 07, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), aChina-based insurance broker, announced today the initial closing of its previously announced best-effort follow-on public offering for the sale of up to 4,800,000 units offered by the Company at a ...

2021-06-08 04:30 13932

Senmiao Technology Announces Over 2.1 Million Completed Rides on its Ride-Hailing Platform in May 2021

CHENGDU, China, June 7, 2021 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced operating metrics for its propr...

2021-06-07 21:00 6348

ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico

RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care ...

2021-06-07 21:00 6497

Elekta's new strategy to focus on growth and access to radiation therapy

STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO,Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the visi...

2021-06-07 20:44 14143

Huya Inc. Joins the Coalition to End Wildlife Trafficking Online, Leveraging Power of Livestreaming for Public Welfare

GUANGZHOU, China, June 7, 2021 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading Chinese livestreaming platform, has joined the Coalition to End Wildlife Trafficking Online (the "Coalition") for World Environment Day which fell onJune 5. It hopes to clean up further th...

2021-06-07 20:31 7736

Ambow Education Inks Strategic Cooperation Agreement with Kylinsoft

BEIJING, June 7, 2021 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or "the Company") (NYSE American: AMBO),China's leading provider of educational and career enhancement services, today announced it has entered into a cooperation agreement ("Cooperation Agreement") with Kylinsoft, a lead...

2021-06-07 20:30 6472

Study of Paxalisib in Primary CNS Lymphoma at Dana-Farber Cancer Institute Enrols First Patient

SYDNEY, June 7, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II study of Kazia's investigational new drug, paxalisib, in primary CNS lymphoma has been initiated at Dana-Farber Cancer Ins...

2021-06-07 20:00 7213

Week's Top Stories